Pasithea Therapeutics Corp.
KTTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001841330
No open-market purchases or sales by Pasithea Therapeutics Corp. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $8.66M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Pasithea Therapeutics Corp. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 11 | 19 | +8 |
| Shares | 300.6K | 612.3K | +311.7K (+103.7%) |
| Value | $216.6K | $441.4K | +$224.8K (+103.8%) |
New holders (10)
Institutions that held Pasithea Therapeutics Corp. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 53,815 | $38.7K | 0.00% |
| Two Sigma Investments, LP | 35,760 | $26.2K | 0.00% |
| XTX Topco Ltd | 34,358 | $24.7K | 0.00% |
| Renaissance Technologies LLC | 30,700 | $22.5K | 0.00% |
| Geode Capital Management, LLC | 25,475 | $18.3K | 0.00% |
| Jane Street Group, LLC | 25,053 | $18.3K | 0.00% |
| Virtu Financial LLC | 25,075 | $18.0K | 0.00% |
| Two Sigma Securities, LLC | 20,846 | $15.3K | 0.00% |
| HRT Financial LP | 10,896 | $7.00K | 0.00% |
| Citigroup Inc | 443 | $319 | 0.00% |
Sold out (2)
Institutions that held Pasithea Therapeutics Corp. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| LPL Financial LLC | 10,000 | $7.21K |
| Raymond James Financial Inc | 1,584 | $1.14K |